Could two blood thinners save more hearts after bypass?
NCT ID NCT03560310
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares two blood thinners (ticagrelor plus aspirin) against aspirin alone after coronary artery bypass grafting (CABG) in people who recently had a heart attack or unstable angina. Over 2,200 participants are being followed for 12 months to see if the dual therapy reduces major heart problems like death, heart attack, or stroke. The goal is to find the best way to protect patients after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ticagrelor and aspirin (acetylsalicylic acid)
What this could lead to
If it works, this could lead to a better standard treatment after heart bypass surgery to prevent future heart attacks, strokes, or death.
What could go wrong
This is a late-stage trial, but adding a second blood thinner increases bleeding risk. The benefit may be small or not outweigh the risks for all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aalborg University Hospital
Aalborg, Denmark
-
Aarhus University Hospital
Aarhus, Denmark
-
Blekinge Hospital
Karlskrona, Sweden
-
Haukeland University Hospital
Trondheim, Norway
-
Helsinki University Hospital
Helsinki, Finland
-
Karolinska University Hospital
Stockholm, Sweden
-
Kuopio University Hospital
Kuopio, Finland
-
Landspítali University Hospital
Reykjavik, Iceland
-
Linköping University Hospital
Linköping, Sweden
-
Odense University Hospital
Odense, Denmark
-
Oslo University Hospital
Oslo, Norway
-
Oulu University Hospital
Oulu, Finland
-
Rigshospitalet
Copenhagen, Denmark
-
Sahlgrenska University Hospital
Gothenburg, Sweden
-
Skåne University Hospital
Lund, Sweden
-
St. Olavs hospital, University Hospital
Bergen, Norway
-
Tampere University Hospital
Tampere, Finland
-
Turku University Hospital
Turku, Finland
-
University Hospital of North Norway
Tromsø, Norway
-
University Hospital of Umeå
Umeå, Sweden
-
Uppsala University Hospital
Uppsala, Sweden
-
Örebro University Hospital
Örebro, Sweden